Michael Lavery

Boston Beer Company Inc's (NYSE:SAM) sales growth in 2025 and 2026 is likely to be slower than was earlier expected, according to Piper Sandler. The Boston Beer Company Analyst: Analyst Michael Lavery downgraded the rating for Boston Beer Company from Overweight to Neutral, while cutting the price...

The uncertainties around PepsiCo Inc's (NASDAQ:PEP) performance in 2025 are already priced into the stock, according to Piper Sandler. The PepsiCo Analyst: Analyst Michael Lavery initiated coverage of PepsiCo with an Overweight rating and a price target of $171. The PepsiCo Thesis: In the back half...

Coca-Cola Co (NYSE:KO) has both attractive and sustainable growth drivers, with the North and Latin American regions driving attractive growth and exposure to emerging markets being a driver of sustainable long-term growth, according to Piper Sandler. The Coca-Cola Analyst: Analyst Michael Lavery...

Shares of Boston Beer Company Inc (NYSE:SAM) were climbing in early trading on Friday, after the company reported its second-quarter results. The results came amid an exciting earnings season. Here are some key analyst takeaways. Goldman Sachs analyst Bonnie Herzog reiterated a Sell rating, while...

With consumer spending taking a hit on elevated interest rates, more economical alcohol brands, especially beer stocks, have been in focus. Analyst Michael Lavery of Piper Sandler initiated coverage of these three beer brands, highlighting their prospects. The Ratings: Molson Coors...

Shares of Monster Beverage Corp (NASDAQ: MNST) continued to recover in early trading on Tuesday, after declining through most of October. Bang Energy had looked like an attractive acquisition, but its sales continue to decline, impacting Monster Beverage’s outlook, according to a Piper...

Consumers are cutting back spending, even on basic goods, due to elevated levels of inflation, according to Piper Sandler. The Tyson Foods Thesis: Analyst Michael Lavery downgraded the rating for Tyson Foods Inc (NYSE: TSN) from Neutral to Underweight, while reducing the price target from $87 to $...

The U.S. cannabis market has the potential to reach $115 billion by 2030, while last year regulated sales in the country have hit $17.5 billion, according to Michael Lavery, a director and senior research analyst covering consumer staples and cannabis for Piper Sandler. “...

Beyond Meat Inc’s (NASDAQ: BYND) momentum across retail channels falls short of consensus expectations, according to Piper Sandler. The Beyond Meat Analyst: Michael Lavery downgraded Beyond Meat from Neutral to Underweight and reduced the price target from $120 to $95. The Beyond Meat...

Hershey Co (NYSE: HSY) is among the best-positioned food companies amid the surge in commodity costs as cocoa prices have remained stable, according to Piper Sandler. The Hershey Company Analyst: Michael Lavery upgraded Hershey Company's stock rating from Neutral to Overweight with a price...

Canadian cannabis companies Tilray Inc. (NASDAQ: TLRY) and Aphria Inc. (NASDAQ: APHA) have agreed to a merger. Meanwhile, Tilray announced strong fourth-quarter results, with meaningful revenue growth and margin expansion. The Tilray Analysts: Michael Lavery of Piper Sandler downgraded...

Tyson Foods, Inc. (NYSE: TSN) could be considered an economic reopening play due to the company's large exposure to the foodservice category, according to Piper Sandler. The Tyson Foods Analyst: Michael Lavery upgraded Tyson Foods from Neutral to Overweight with a price target lifted from $70...

Plant-based food maker Beyond Meat Inc (NASDAQ: BYND) reported third-quarter earnings that notably fell short of expectations and sparked a debate among analysts. The Analysts: CFRA analyst Arun Sundaram maintains a Sell rating on Beyond Meat's stock with a price target lowered from $100 to $80...

Some of the most high-profile cannabis analysts shared their insights in a thrilling discussion about trends, strategies and forecasts at the Virtual Benzinga Cannabis Capital Conference. Alan Brochstein, the founder of 420 Investor and New Cannabis Ventures, led the discussion. Cresco, Green Thumb...

Aurora Cannabis Inc (NYSE: ACB)(TSE:ACB) reported a 35% sequential sales increase for the third quarter to far exceed analyst expectations. While its EBITDA loss was about $10 million worse than consensus forecasted, international medical sales and Canadian recreational sales beat estimates,...